Colgate/$CL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Colgate

Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for north of 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one-fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.

Ticker

$CL

Primary listing

NYSE

Employees

34,000

Colgate Metrics

BasicAdvanced
$68B
23.67
$3.56
0.37
$2.04
2.47%

What the Analysts think about Colgate

Analyst ratings (Buy, Hold, Sell) for Colgate stock.

Bulls say / Bears say

Colgate-Palmolive beat first-quarter net sales and adjusted EPS expectations, reporting $4.91 billion in net sales versus $4.87 billion forecast and $0.91 EPS against $0.86 expected, while gross profit margin improved by 80 basis points to 60.8% (Reuters)
The company raised its full-year organic sales growth forecast to 2%–4% from its prior 3%–5% range, reflecting management’s confidence in sustaining pricing power and demand resilience (Reuters)
Regional performance was strong, with sales up 8% in Africa and 7.8% in Europe in the June quarter, highlighting growing momentum in key emerging markets (Reuters)
Total organic volumes slipped 0.2% in the quarter ended June 30 despite a 2% price increase, signaling potential consumer resistance to ongoing price hikes and risking further volume declines (Reuters)
First-quarter organic sales growth was a modest 1.4%, pointing to limited top-line momentum and underscoring the challenge of driving meaningful volume expansion (Reuters)
Tariff-related costs are now expected to add about $200 million to cost of goods sold in 2025, creating a significant headwind for margins despite cost-cutting efforts (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2025.

Colgate Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Colgate Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CL

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs